{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:30:11Z","timestamp":1795026611222,"version":"4.10.2"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific and technological innovation project of China Academy of Chinese Medical Sciences","award":["No.CI2021A00801"],"award-info":[{"award-number":["No.CI2021A00801"]}]},{"name":"Sanming Proiect of Medicine in Shenzhen","award":["No.SZZYSM202311014"],"award-info":[{"award-number":["No.SZZYSM202311014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91312-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:55:25Z","timestamp":1740729325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021"],"prefix":"10.1038","volume":"15","author":[{"given":"Ziwei","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"91312_CR1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835 (2023).","journal-title":"Hepatology"},{"key":"91312_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jama.2023.17935","volume":"330","author":"PB Leung","year":"2023","unstructured":"Leung, P. B., Davis, A. M. & Kumar, S. Diagnosis and management of nonalcoholic fatty liver disease. Jama 330, 1687\u20131688 (2023).","journal-title":"Jama"},{"key":"91312_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"91312_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW Wong","year":"2023","unstructured":"Wong, V. W., Ekstedt, M., Wong, G. L. & Hagstr\u00f6m, H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79, 842\u2013852 (2023).","journal-title":"J. Hepatol."},{"key":"91312_CR5","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"E En Li Cho","year":"2023","unstructured":"En Li Cho, E. et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: An updated systematic review and meta-analysis. Gut 72, 2138\u20132148 (2023).","journal-title":"Gut"},{"key":"91312_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander, C., Grabherr, F. & Tilg, H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc. Res. 119, 1787\u20131798 (2023).","journal-title":"Cardiovasc. Res."},{"key":"91312_CR7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J. & George, J. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999\u20132014 (2020). e1991.","journal-title":"Gastroenterology"},{"key":"91312_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/hepr.13706","volume":"52","author":"T Kawaguchi","year":"2022","unstructured":"Kawaguchi, T., Tsutsumi, T., Nakano, D. & Torimura, T. MAFLD: Renovation of clinical practice and disease awareness of fatty liver. Hepatol. Res. 52, 422\u2013432 (2022).","journal-title":"Hepatol. Res."},{"key":"91312_CR9","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","volume":"79","author":"AL Hutchison","year":"2023","unstructured":"Hutchison, A. L., Tavaglione, F., Romeo, S. & Charlton, M. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): beyond insulin resistance. J. Hepatol. 79, 1524\u20131541 (2023).","journal-title":"J. Hepatol."},{"key":"91312_CR10","first-page":"691","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. MASLD: A systemic metabolic disorder with cardiovascular and malignant complications. Gut 73, 691\u2013702 (2024).","journal-title":"Gut"},{"key":"91312_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.21037\/hbsn-22-421","volume":"12","author":"DQ Sun","year":"2023","unstructured":"Sun, D. Q. et al. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surg. Nutr. 12, 386\u2013403 (2023).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"91312_CR12","first-page":"955","volume":"12","author":"JG Fan","year":"2024","unstructured":"Fan, J. G. et al. Guideline for the prevention and treatment of metabolic Dysfunction-associated fatty liver disease (Version 2024). J. Clin. Transl Hepatol. 12, 955\u2013974 (2024).","journal-title":"J. Clin. Transl Hepatol."},{"key":"91312_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21037\/hbsn-23-556","volume":"13","author":"TW Lou","year":"2024","unstructured":"Lou, T. W., Yang, R. X. & Fan, J. G. The global burden of fatty liver disease: The major impact of China. Hepatobiliary Surg. Nutr. 13, 119\u2013123 (2024).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"91312_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology 77, 1335\u20131347 (2023).","journal-title":"Hepatology"},{"key":"91312_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B. & Loomba, R. Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 18, 223\u2013238 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"91312_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","volume":"20","author":"LA Orci","year":"2022","unstructured":"Orci, L. A. et al. Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review, Meta-analysis, and Meta-regression. Clin. Gastroenterol. Hepatol. 20, 283\u2013292e210 (2022).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"91312_CR17","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69, 2672\u20132682 (2019).","journal-title":"Hepatology"},{"key":"91312_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"91312_CR19","doi-asserted-by":"publisher","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","volume":"111s","author":"A Mantovani","year":"2020","unstructured":"Mantovani, A. et al. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism 111s, 154170 (2020).","journal-title":"Metabolism"},{"key":"91312_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/hep.32542","volume":"77","author":"PA Shah","year":"2023","unstructured":"Shah, P. A., Patil, R. & Harrison, S. A. NAFLD-related hepatocellular carcinoma: The growing challenge. Hepatology 77, 323\u2013338 (2023).","journal-title":"Hepatology"},{"key":"91312_CR21","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","volume":"28","author":"CJL Murray","year":"2022","unstructured":"Murray, C. J. L. The global burden of disease study at 30 years. Nat. Med. 28, 2019\u20132026 (2022).","journal-title":"Nat. Med."},{"key":"91312_CR22","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1016\/S0140-6736(24)00769-4","volume":"403","author":"CJL Murray","year":"2024","unstructured":"Murray, C. J. L. Findings from the global burden of disease study 2021. Lancet 403, 2259\u20132262 (2024).","journal-title":"Lancet"},{"key":"91312_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","volume":"24","author":"GBDLR Infections","year":"2024","unstructured":"Infections, G. B. D. L. R. & Antimicrobial Resistance, C. Global, regional, and National incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990\u20132021: A systematic analysis from the global burden of disease study 2021. Lancet Infect. Dis. 24, 974\u20131002 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"91312_CR24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1097\/JS9.0000000000001071","volume":"110","author":"F Wang","year":"2024","unstructured":"Wang, F., Ma, B., Ma, Q. & Liu, X. Global, regional, and National burden of inguinal, femoral, and abdominal hernias: A systematic analysis of prevalence, incidence, deaths, and dalys with projections to 2030. Int. J. Surg. 110, 1951\u20131967 (2024).","journal-title":"Int. J. Surg."},{"key":"91312_CR25","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"Global burden","year":"2024","unstructured":"Global burden. Of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the global burden of disease study 2021. Lancet 403, 2100\u20132132 (2024).","journal-title":"Lancet"},{"key":"91312_CR26","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"Global age-sex","year":"2024","unstructured":"Global age-sex. -specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: A comprehensive demographic analysis for the global burden of disease study 2021. Lancet 403, 1989\u20132056 (2024).","journal-title":"Lancet"},{"key":"91312_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"Global","year":"2023","unstructured":"Global & national burden of diabetes. From 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the global burden of disease study 2021. Lancet 402, 203\u2013234 (2023).","journal-title":"Lancet"},{"key":"91312_CR28","doi-asserted-by":"publisher","first-page":"29034","DOI":"10.3402\/gha.v8.29034","volume":"8","author":"AR Hosseinpoor","year":"2015","unstructured":"Hosseinpoor, A. R., Bergen, N. & Schlotheuber, A. Promoting health equity: WHO health inequality monitoring at global and National levels. Glob Health Action. 8, 29034 (2015).","journal-title":"Glob Health Action"},{"key":"91312_CR29","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.arr.2024.102382","volume":"99","author":"F Cao","year":"2024","unstructured":"Cao, F. et al. Trends and cross-country inequalities in the global burden of osteoarthritis, 1990\u20132019: A population-based study. Ageing Res. Rev. 99, 102382 (2024).","journal-title":"Ageing Res. Rev."},{"key":"91312_CR30","doi-asserted-by":"crossref","unstructured":"Bai, Z. et al. The global, regional, and National patterns of change in the burden of non-malignant upper Gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade. Int. J. Surg. (2024).","DOI":"10.1097\/JS9.0000000000001902"},{"key":"91312_CR31","doi-asserted-by":"crossref","unstructured":"Lu, F. et al. Global trends and inequalities of liver complications related to metabolic Dysfunction-Associated steatotic liver disease: An analysis from 1990 to 2021. Liver Int 2024.","DOI":"10.1111\/liv.16120"},{"key":"91312_CR32","doi-asserted-by":"publisher","first-page":"103498","DOI":"10.1016\/j.autrev.2023.103498","volume":"23","author":"S Wang","year":"2024","unstructured":"Wang, S., Dong, Z. & Wan, X. Global, regional, and National burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: An analysis of the global burden of disease study 2019. Autoimmun. Rev. 23, 103498 (2024).","journal-title":"Autoimmun. Rev."},{"key":"91312_CR33","doi-asserted-by":"publisher","first-page":"106250","DOI":"10.1016\/j.jinf.2024.106250","volume":"89","author":"D Huang","year":"2024","unstructured":"Huang, D. et al. Global Temporal trends and projections of acute hepatitis E incidence among women of childbearing age: Age-period-cohort analysis 2021. J. Infect. 89, 106250 (2024).","journal-title":"J. Infect."},{"key":"91312_CR34","doi-asserted-by":"publisher","first-page":"04120","DOI":"10.7189\/jogh.13.04120","volume":"13","author":"J Xiao","year":"2023","unstructured":"Xiao, J. et al. Downward trends in the global burden of congenital complete hearing loss in children younger than five years from 1990 to 2030. J. Glob Health. 13, 04120 (2023).","journal-title":"J. Glob Health"},{"key":"91312_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","volume":"20","author":"M Knoll","year":"2020","unstructured":"Knoll, M. et al. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med. Res. Methodol. 20, 257 (2020).","journal-title":"BMC Med. Res. Methodol."},{"key":"91312_CR36","first-page":"64","volume":"11","author":"H Zi","year":"2024","unstructured":"Zi, H. et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med. Res. 11, 64 (2024).","journal-title":"Mil Med. Res."},{"key":"91312_CR37","doi-asserted-by":"crossref","unstructured":"Kuang, Z. et al. Global, regional, and national burden of tracheal, bronchus, and lung cancer and its risk factors from 1990 to 2021: findings from the global burden of disease study 2021. EClinicalMedicine. ;75:102804. (2024).","DOI":"10.1016\/j.eclinm.2024.102804"},{"key":"91312_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1008953201688","volume":"11","author":"BF Hankey","year":"2000","unstructured":"Hankey, B. F. et al. Partitioning linear trends in age-adjusted rates. Cancer Causes Control. 11, 31\u201335 (2000).","journal-title":"Cancer Causes Control"},{"key":"91312_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79, 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"key":"91312_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","volume":"72","author":"CD Byrne","year":"2020","unstructured":"Byrne, C. D. & Targher, G. NAFLD as a driver of chronic kidney disease. J. Hepatol. 72, 785\u2013801 (2020).","journal-title":"J. Hepatol."},{"key":"91312_CR41","doi-asserted-by":"publisher","first-page":"1125829","DOI":"10.3389\/fendo.2023.1125829","volume":"14","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning. Front. Endocrinol. (Lausanne). 14, 1125829 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"91312_CR42","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. NAFLD and increased risk of cardiovascular disease: Clinical associations, pathophysiological mechanisms and Pharmacological implications. Gut 69, 1691\u20131705 (2020).","journal-title":"Gut"},{"key":"91312_CR43","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","volume":"76","author":"PK Luukkonen","year":"2022","unstructured":"Luukkonen, P. K. et al. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. J. Hepatol. 76, 526\u2013535 (2022).","journal-title":"J. Hepatol."},{"key":"91312_CR44","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","volume":"37","author":"S Yuan","year":"2022","unstructured":"Yuan, S. et al. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study. Eur. J. Epidemiol. 37, 723\u2013733 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"91312_CR45","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1111\/liv.14638","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease. Liver Int. 40, 2719\u20132731 (2020).","journal-title":"Liver Int."},{"key":"91312_CR46","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2147\/CIA.S295524","volume":"16","author":"SA Alqahtani","year":"2021","unstructured":"Alqahtani, S. A. & Schattenberg, J. M. NAFLD in the elderly. Clin. Interv Aging. 16, 1633\u20131649 (2021).","journal-title":"Clin. Interv Aging"},{"key":"91312_CR47","doi-asserted-by":"crossref","unstructured":"Chen, H. et al. Sex- and age-specific associations between abdominal fat and non-alcoholic fatty liver disease: A prospective cohort study. J. Mol. Cell. Biol. ;15. (2024).","DOI":"10.1093\/jmcb\/mjad069"},{"key":"91312_CR48","doi-asserted-by":"publisher","first-page":"101833","DOI":"10.1016\/j.arr.2022.101833","volume":"84","author":"Y He","year":"2023","unstructured":"He, Y. et al. Emerging role of aging in the progression of NAFLD to HCC. Ageing Res. Rev. 84, 101833 (2023).","journal-title":"Ageing Res. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91312-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T07:55:35Z","timestamp":1740729335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91312"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91312-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants in this study consented to publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"For the GBD, which is publicly available, and no identifiable information was included in the analyses, the \u2018Ethical approval and Ethics Approval and Consent to Participate\u2019 was not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"7083"}}